Anand Patel1, Howard L. Kaufman1, Mary L. Disis2
1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA; 2Tumor Vaccine Group, University of Washington, Seattle, WA, USA
Contributions: (I) Conception and design: HL Kaufman, ML Disis; (II) Administrative support: HL Kaufman; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: A Patel, HL Kaufman; (V) Data analysis and interpretation: HL Kaufman, ML Disis; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
Correspondence to: Howard L. Kaufman, MD. Associate Director for Clinical Science, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, Room 2004, New Brunswick, NJ 08901, USA. Email: email@example.com.